Advertisement
Advertisement
U.S. markets close in 43 minutes
Advertisement
Advertisement
Advertisement
Advertisement

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
29.40+0.37 (+1.27%)
As of 03:16PM EDT. Market open.
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
35,000
0
Operating Expense
280,674
280,674
173,468
81,324
59,239
Operating Income
-280,674
-280,674
-173,468
-46,324
-59,239
Net Non Operating Interest Income Expense
6,285
6,285
698
1,330
3,547
Other Income Expense
-3,028
-3,028
-1,140
-580
-2,614
Pretax Income
-277,417
-277,417
-173,910
-45,574
-58,306
Net Income Common Stockholders
-277,417
-277,417
-173,910
-45,574
-50,577
Diluted NI Available to Com Stockholders
-277,417
-277,417
-173,910
-45,574
-50,577
Basic EPS
-
-
-3.59
-1.05
-3.81
Diluted EPS
-
-
-3.59
-1.05
-3.81
Basic Average Shares
-
-
48,498
43,300
13,275
Diluted Average Shares
-
-
48,498
43,300
13,275
Total Operating Income as Reported
-280,674
-280,674
-173,468
-46,324
-59,239
Total Expenses
280,674
280,674
173,468
81,324
59,239
Net Income from Continuing & Discontinued Operation
-277,417
-277,417
-173,910
-45,574
-58,306
Normalized Income
-277,417
-277,417
-173,910
-45,574
-58,306
Interest Income
6,285
6,285
698
1,330
3,547
Net Interest Income
6,285
6,285
698
1,330
3,547
EBIT
-280,674
-280,674
-173,468
-46,324
-59,239
EBITDA
-279,909
-
-
-
-
Reconciled Depreciation
765
765
490
349
192
Net Income from Continuing Operation Net Minority Interest
-277,417
-277,417
-173,910
-45,574
-58,306
Normalized EBITDA
-279,909
-279,909
-172,978
-45,975
-59,047
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement